E.O.L. (Inlight Creation, LLC)
Welcome to the PulseAid listing for the E.O.L. drug offered from Inlight Creation, LLC. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Inlight Creation, LLC |
NON-PROPRIETARY NAME: | Stollingia Sylvatica, Zincum Gluconicum, Thiaminum Hydrochloricum, Fragaria Vesca, Niacin Serotonin, 5-Hydroxytryptophan, Betainum Murriatium, Biotin, Cholinum, Coconut Oil, CO Q 10, DL-Methionine, L- |
SUBSTANCE NAME: | STILLINGIA SYLVATICA ROOT; ZINC GLUCONATE; THIAMINE HYDROCHLORIDE; ALPINE STRAWBERRY; NIACIN; SEROTONIN; OXITRIPTAN; BETAINE HYDROCHLORIDE; BIOTIN; CHOLINE HYDROXIDE; COCONUT OIL; UBIDECARENONE; RACEM |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | LIQUID |
MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
START MARKETING DATE: | 2013-10-10 |
END MARKETING DATE: | 0000-00-00 |
E.O.L. HUMAN OTC DRUG Details:
Item Description | E.O.L. from Inlight Creation, LLC |
LABELER NAME: | Inlight Creation, LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 3; 3; 4; 5; 5; 5; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 7; 7; 7; 7; 7; 8; 8; 8; 8; 12; 17; 18; 6; 30; 30; 30([hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [h) |
START MARKETING DATE: | 2013-10-10 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 53405-0001_c4d2c738-e285-4518-9455-e33924dbe76e |
PRODUCT NDC: | 53405-0001 |
APPLICATION NUMBER: | |
Other STILLINGIA SYLVATICA ROOT; ZINC GLUCONATE; THIAMINE HYDROCHLORIDE; ALPINE STRAWBERRY; NIACIN; SEROTONIN; OXITRIPTAN; BETAINE HYDROCHLORIDE; BIOTIN; CHOLINE HYDROXIDE; COCONUT OIL; UBIDECARENONE; RACEM Pharmaceutical Manufacturers / Labelers: